Biotech

All Articles

Lilly messages more favorable data on its own once a week insulin possibility

.On the heels of an FDA being rejected for its own primary competing Novo Nordisk, Eli Lilly is actu...

IN 8bio stops phase 2 test, lays off one-half of labor force

.Simply a couple of months after application the very first person in a period 2 test for newly iden...

Lilly, Haya ink $1B biobuck excessive weight deal to browse darker genome

.Eli Lilly's look for excessive weight intendeds has led it to the darker genome. The Big Pharma has...

ArsenalBio increases $325M, rotates away from former lead asset

.Arsenal Biosciences is going on up. The cell treatment company has actually added on $325 thousand ...

Lilly- backed weight reduction biotech data IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has filed to de...

Aelis' marijuana usage medicine flunks phase 2b, steering Indivior to review $100M possibility

.Aelis Farma's chances of safeguarding an easy, beneficial selection on a $100 million alternative s...

ProKidney halts stage 3 trial not needed to have for tissue treatment confirmation

.ProKidney has stopped among a set of period 3 trials for its tissue therapy for kidney condition af...

Vaxcyte surges on 'sensational' 31-valent PCV win against Pfizer

.Vaxcyte unveiled what analysts called "impressive" phase 1/2 data for its 31-valent pneumococcal va...

Recursion's human brain illness test presents scant documentation of efficiency

.Recursion has actually stumbled via an early test of its tech-enabled technique to medicine revelat...

Acepodia, Pfizer click on with each other for chemistry-based tissue therapy

.Call it an instance of really good chemistry: Acepodia, a biotech based upon Nobel Prize-winning sc...